Other companies have failed in efforts to market alternatives to needles for diabetics
. In 2001, Cygnus Inc. won FDA approval for
its GlucoWatch, a blood
-sugar meter that could be worn like a wristwatch.
But the device was eventually discontinued amid complaints it was not accurate and caused skin irritation in some users. Johnson & Johnson, which now reportedly owns the technology, did not return calls seeking comment.
In addition, several companies, including Pfizer Inc.